
zzso is a zzso zzso of zzso with broad zzso activity and high specificity for tumor zzso Its zzso effects are particularly suited to reversal of zzso and the drug is being developed as a zzso of standard zzso in solid zzso This phase I, zzso trial was conducted to test a continuous intravenous dosing regimen of zzso in patients with zzso solid tumors to determine zzso zzso and preliminary zzso 

zzso given by intravenous infusion continuously for 7 days on zzso cycles was zzso on an zzso basis at zzso of zzso zzso zzso and zzso zzso (three to four patients per zzso Treatment cycles continued until disease zzso zzso was based on standard zzso efficacy was based on changes in tumor burden zzso zzso analysis was conducted on plasma samples at specified time points during treatment zzso 

zzso zzso patients with solid tumors received a median of three cycles of treatment zzso zzso two patients received zzso 12 zzso No zzso zzso were encountered, with zzso and fatigue (one zzso and rash (one zzso the only significant zzso zzso disease was the best efficacy outcome, with one patient showing stable disease at 24 zzso zzso suggested a linear relationship between dosage and mean zzso plasma zzso of zzso 

A zzso continuous infusion of zzso given every 2 weeks is well tolerated up to a dose of zzso zzso 

